Schubert & CO United Therapeutics Corp Transaction History

Schubert & CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 02, 2023	SELL	$212.99 - $276.17 $851 - $1,104	-4 Reduced 11.11%	32 $7,000
Q4 2022 Jan 31, 2023	BUY	$205.95 - $280.43 $1,235 - $1,682	6 Added 20.0%	36 $10,000
Q3 2022 Oct 21, 2022	SELL	$203.3 - $244.17 $203 - $244	-1 Reduced 3.23%	30 $6,000
Q2 2022 Aug 01, 2022	BUY	$174.81 - $241.14 $4,020 - $5,546	23 Added 287.5%	31 $7,000
Q1 2022 May 16, 2022	SELL	$166.16 - $213.96 $332 - $427	-2 Reduced 20.0%	8 $1,000
Q4 2021 Jan 28, 2022	BUY	$184.32 - $216.08 $1,843 - $2,160	10 New	10 $2,000

668

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.6B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of Schubert & CO, based on Form 13F filings with the SEC.

Stay updated on Schubert & CO with notifications on news.